SafeWire Serves as Sponsor for One Spine Residents and Fellows Course

Stanmore Medical Investments is pleased to announce that Safewire, a Medvest Fund One portfolio company, was an industry sponsor for the 4th Annual One Spine Residents and Fellows Course at the prestigious Swedish Neuroscience Institute in Seattle, WA, held over the weekend of August 16-18.  In collaboration with renowned faculty, Safewire provided training in the principals of minimally invasive spine surgery to an international group of senior surgical residents and spine fellows.

This event marks the beginning of Safewire’s focus on providing in-depth surgeon training on the principals of safer and more efficient techniques for performing minimally invasive spine surgery.  With a recent investment from Medvest Fund One and strategic planning provided by SMI, Safewire will be busy over the next 18 months launching exciting new product line extensions to its Y-Wire and Tiger Needle products.  As Safewire adds to its team of seasoned sales and marketing staff, it will be participating in additional events like One Spine.

Safewire LLC is headquartered in Cooper City, Florida (www.safe-wire.com).  The Company’s purpose is to improve outcomes by creating instrument systems specifically designed to facilitate minimally invasive surgical procedures.  The Company currently sells a guide wire product called Y-Wire which is designed to reduce inadvertent advancement and to decrease the amount of fluoroscopy during surgical procedures.  Additionally, Safewire sells a Jamshidi needle product designed to provide surgeons with improved depth control within the vertebral body by offering a mechanically controlled tip.  This needle, known as Tiger Needle, also integrates a technology designed to complement placement of Y-Wire.

Medvest Fund One is an $8.0 million private equity fund targeting medical device and technology companies who are positioned for growth and share the Fund’s core values.  The Fund is accepting subscriptions.  For more information contact David Cash at (561) 459-3333 or [email protected]

Scroll to top